Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23a4e0c875bf1ac2b8a3b76517de6c7d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-38022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-00022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2820-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-00023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-609 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
filingDate |
2020-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f23350d83212c8edb2b645666d75aea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d8f2b5fa6e0e903a05b9bb9a5bca8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a90136d125ce7f998b32920e2034c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4846fa600dfa132d6acf74b20c54b3ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd684b97e8c479ffbd51743cac2c6917 |
publicationDate |
2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020277613-A1 |
titleOfInvention |
Nanoparticles and biotemplates with tunable length and methods of manufacturing the same |
abstract |
Methods and nucleic acid sequences for the synthesis of biotemplates in a non-plant based expression system are provided. Such biotemplates include Barley stripe mosaic virus viral-like particles (BSMV-VLPs) that are capable of self-assembly due to being operatively linked with an origin of self-assembly with the Barley stripe mosaic virus capsid protein (BSMV-CP). Also provided are BSMV-VLPs that are capable of self-assembly due one or more site-directed mutations on the BSMV-CP, and BSMV-VLPs that exhibit enhanced stability due to such site-directed mutation(s). |
priorityDate |
2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |